News Cuvrior Approved for Life-Threatening Genetic Disorder May 2, 2022 Read More » First Therapeutically Equivalent Velcade Generics Approved May 2, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in May May 1, 2022 Read More » Rinvoq Now Indicated for Ankylosing Spondylitis April 29, 2022 Read More » Ultomiris Granted New Myasthenia Gravis Indication April 28, 2022 Read More » Vivjoa Approved to Treat Chronic Yeast Infections April 28, 2022 Read More » First-in-Class Treatment Approved for Hypertrophic Cardiomyopathy April 28, 2022 Read More » New Caplyta Dosage Strengths Approved April 25, 2022 Read More » FDA Approves New Benzoyl Peroxide Product for Rosacea April 25, 2022 Read More » Page1 … Page32 Page33 Page34 Page35 Page36 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in May May 1, 2022 Read More »